Immuneering (IMRX) Shares Outstanding (2020 - 2024)
Immuneering (IMRX) has 3 years of Shares Outstanding data on record, last reported at $26.4 million in Q4 2022.
- For Q4 2022, Shares Outstanding changed 0.37% year-over-year to $26.4 million; the TTM value through Dec 2022 reached $26.4 million, changed 0.37%, while the annual FY2022 figure was $26.4 million, 0.37% changed from the prior year.
- Shares Outstanding reached $26.4 million in Q4 2022 per IMRX's latest filing, roughly flat from $26.4 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $26.4 million in Q4 2022 and bottomed at $5.0 million in Q2 2020.
- Average Shares Outstanding over 3 years is $16.6 million, with a median of $25.9 million recorded in 2021.
- The widest YoY moves for Shares Outstanding: up 432.98% in 2022, down 0.37% in 2022.
- A 3-year view of Shares Outstanding shows it stood at $5.0 million in 2020, then skyrocketed by 431.71% to $26.3 million in 2021, then rose by 0.37% to $26.4 million in 2022.
- Per Business Quant database, its latest 3 readings for Shares Outstanding were $26.4 million in Q4 2022, $26.4 million in Q3 2022, and $26.4 million in Q2 2022.